Trial intelligence / Profile preview

Morphine vs Methadone for Neonatal Abstinence Syndrome

NCT02851303Phase 4Completed

Sponsor
The University of New Mexico
Start
Oct 2016
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of morphine in neonatal abstinence syndrome (NAS), sponsored by The University of New Mexico. Primary endpoint: Length of Hospital Stay. Started Oct 2016; status: completed.

02

Drugs

morphine
03

Conditions

neonatal abstinence syndrome (NAS)

Beyond the preview

Go deeper on NCT02851303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02851303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call